CellWell record HH-382923
TSH Stimulation Methods are Associated with Comparable Outcomes in Radioiodine-Avid Metastatic Differentiated Thyroid Cancer: Single Center Retrospective Observational Study
Aleksandra Ledwon; E. Paliczka-Cieślik; A. Kropińska; Aleksandra Blewąska; A. Czarniecka; E. Chmielik; J. Krajewska; P. Cieślik; B. Jarząb; D. Handkiewicz-Junak
Thyroid · 2026
In plain language
Recombinant TSH and thyroid hormone withdrawal stimulation produced comparable radioiodine therapy outcomes in metastatic differentiated thyroid cancer.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-382923
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.